Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract
NCT00619827
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
89
Enrollment
INDUSTRY
Sponsor class
Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG:
300 IR grass pollen allergen extract tablet
DRUG:
Placebo tablet
Sponsor
Stallergenes Greer